These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6218564)

  • 1. An evaluation of the toxicity of moxalactam in laboratory animals.
    Harada Y; Kobayashi F; Muraoka Y; Hasegawa Y; Wold JS; Morton DM
    Rev Infect Dis; 1982; 4 Suppl():S536-45. PubMed ID: 6218564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal pharmacokinetics and toxicology of cefotetan--a new cephamycin antibiotic.
    Suzuki H; Imamura K; Yoshida T; Shibata M; Matsuzawa T; Ozaki H; Sakai T; Shiobara Y; Tachibana A; Yano K
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():179-83. PubMed ID: 6573314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicologic evaluation of cefamandole nafate in laboratory animals.
    Wold JS; Welles JS; Owen NV; Gibson WR; Morton DM
    J Infect Dis; 1978 May; 137 Suppl():S51-S59. PubMed ID: 650004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and reproduction studies of ceftizoxime sodium.
    Fukuhara K; Emi Y; Iwanami K; Furukawa T; Fujii T; Itoh N; Katsuki S; Yoshimitsu H; Ii Y; Watanabe N
    Arzneimittelforschung; 1980; 30(10):1669-79. PubMed ID: 6933994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
    Harada Y; Teshima K; Okamoto T
    Jpn J Antibiot; 1981 Dec; 34(12):1549-70. PubMed ID: 6460885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of Moxalactam (6059-S): the chemistry and biology of 1-oxacephems.
    Otsuka H; Nagata W; Yoshioka M; Narisada M; Yoshida T; Harada Y; Yamada H
    Med Res Rev; 1981; 1(3):217-48. PubMed ID: 6213825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol-moxalactam interactions in vivo.
    Buening MK; Wold JS
    Rev Infect Dis; 1982; 4 Suppl():S555-63. PubMed ID: 6218566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis.
    Shimada J; Yamaji T; Miyahara T; Ueda Y; Kawabata T; Sugeno K; Yoshida T; Nakamura M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):8-14. PubMed ID: 6219621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic toxicity study of latamoxef in beagle dog (author's transl)].
    Muraoka Y; Nara H; Yoshizaki T; Harada Y
    Jpn J Antibiot; 1982 Jan; 35(1):222-39. PubMed ID: 6461778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals.
    Komiya M; Kikuchi Y; Tachibana A; Yano K
    Antimicrob Agents Chemother; 1981 Aug; 20(2):176-83. PubMed ID: 6945066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of moxalactam and cefotaxime on rabbit renal tissue.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Blase DK; Gattone VH
    Antimicrob Agents Chemother; 1982 May; 21(5):830-5. PubMed ID: 6285815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis.
    Leeds NH; Peyman GA; House B
    Ophthalmic Surg; 1982 Aug; 13(8):653-6. PubMed ID: 6215601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute, subchronic and chronic toxicity of the new angiotensin converting enzyme inhibitor ramipril.
    Donaubauer HH; Mayer D
    Arzneimittelforschung; 1988 Jan; 38(1):14-20. PubMed ID: 2966628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A species comparison of the toxicity of nabilone, a new synthetic cannabinoid.
    Hanasono GK; Sullivan HR; Gries CL; Jordan WH; Emmerson JL
    Fundam Appl Toxicol; 1987 Aug; 9(2):185-97. PubMed ID: 2888699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.